24/7 Market News Snapshot 13 March, 2025 – Femasys Inc. Common Stock (NASDAQ:FEMY)

March 13, 2025

DENVER, Colo., 13 March, 2025 (247marketnews.com) – (Nasdaq:FEMY) are discussed in this article.
Femasys Inc. (Nasdaq:FEMY) is experiencing a significant upward trend in its stock performance, with pre-market trading showing a price of $1.605, representing a robust increase of approximately 9.93% from the previous closing price of $1.460. This surge is accompanied by an impressive trading volume of 2.53 million shares, indicating heightened investor interest and suggesting a potential continuing momentum that traders should monitor closely, particularly regarding key resistance levels and support areas.

This market activity coincides with a pivotal announcement from Femasys, as the company has recently attained the Conformité Européenne (CE) mark certification for its FemBloc® delivery system. This achievement marks a groundbreaking moment in women’s reproductive health, establishing FemBloc as the first non-surgical permanent birth control method to receive regulatory approval globally. The FemBloc delivery system is designed to offer a safer, less invasive alternative to traditional surgical sterilization methods, which have long been the standard in permanent contraception.

The CE mark certification follows the successful completion of an expedited medical device regulation audit and underscores Femasys’s commitment to addressing the unmet needs in women’s health. Kathy Lee-Sepsick, the CEO and Founder, highlighted the significance of regulatory collaboration in accelerating this process, stating that this milestone reflects a transformative opportunity for women seeking non-surgical contraceptive options.

Looking ahead, Femasys is actively preparing for a market launch in selected regions while continuing to enroll participants for its FDA-approved pivotal clinical trial. The firm remains dedicated to innovating women’s health solutions, bolstered by its extensive portfolio of patent-protected products, and aims to empower women through accessible and safe reproductive healthcare choices.

Related news for (FEMY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.